Ryuji Kaji Selected Research

rimabotulinumtoxinB

1/2022	[Safety and Efficacy of Rimabotulinumtoxin B in Patients with Cervical Dystonia in Observational Study].
12/2021	Efficacy of botulinum toxin type B (rimabotulinumtoxinB) in patients with cervical dystonia previously treated with botulinum toxin type A: A post-marketing observational study in Japan.
2/2013	[A double-blind comparative study to evaluate the efficacy and safety of NerBloc® (rimabotulinumtoxinB) administered in a single dose to patients with cervical dystonia].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryuji Kaji Research Topics

Disease

24	Parkinson Disease (Parkinson's Disease) 02/2020 - 07/2002
22	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 03/2003
19	Dystonia (Limb Dystonia) 09/2020 - 11/2005
14	Stroke (Strokes) 01/2022 - 02/2010
7	Multiple System Atrophy 02/2020 - 07/2002
5	Torticollis (Wryneck) 01/2022 - 01/2012
4	Movement Disorders (Movement Disorder) 05/2021 - 10/2008
4	Guillain-Barre Syndrome 12/2020 - 03/2005
4	Nervous System Diseases (Neurological Disorders) 10/2018 - 01/2011
4	Muscle Weakness 07/2015 - 04/2002
4	Dystonic Disorders (Writer's Cramp) 01/2014 - 01/2005
3	Spasm (Spasms) 01/2018 - 05/2003
3	Dyskinesias (Dyskinesia) 12/2017 - 03/2006
3	Alzheimer Disease (Alzheimer's Disease) 11/2017 - 09/2004
3	Demyelinating Diseases (Demyelinating Disease) 05/2016 - 08/2006
3	Hyperkinesis 01/2016 - 03/2006
3	Motor Neuron Disease (Primary Lateral Sclerosis) 07/2015 - 03/2008
3	Dementia (Dementias) 04/2015 - 09/2009
2	Pain (Aches) 12/2021 - 01/2020
2	Thymoma (Thymic Carcinoma) 11/2021 - 03/2016
2	Tardive Dyskinesia 05/2021 - 10/2008
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 02/2020 - 11/2014
2	Sarcoma (Soft Tissue Sarcoma) 02/2019 - 02/2011
2	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2019 - 10/2017
2	Hereditary Spastic Paraplegia 01/2019 - 05/2016
2	Stiff-Person Syndrome (Stiff Man Syndrome) 04/2018 - 10/2013
2	Synucleinopathies 01/2018 - 11/2014
2	Deglutition Disorders (Dysphagia) 01/2018 - 02/2013
2	Infections 01/2018 - 10/2011
2	Myasthenia Gravis 10/2017 - 12/2013
2	Hemifacial Spasm 09/2017 - 01/2016
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 09/2017 - 03/2012
2	Pathologic Constriction (Stenosis) 08/2017 - 01/2014
2	Parkinsonian Disorders (Parkinsonism) 06/2017 - 04/2007
2	Disease Progression 04/2016 - 01/2010
2	Peripheral Nervous System Diseases (PNS Diseases) 09/2015 - 01/2014
2	Central Nervous System Diseases (CNS Diseases) 03/2015 - 11/2007
2	Camptocormia 11/2014 - 05/2009
2	Sporadic Creutzfeldt-Jakob Disease 11/2013 - 05/2012
2	Temporal Lobe Epilepsy 11/2013 - 06/2003
2	Seizures (Absence Seizure) 11/2013 - 03/2003
2	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 10/2012 - 10/2012
2	Meige Syndrome 01/2012 - 02/2011
2	Fasciculation (Fasciculations) 11/2011 - 03/2008
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2011 - 08/2008
2	Polymyositis 09/2011 - 10/2010
2	Dystonia musculorum deformans type 1 10/2006 - 03/2006
2	T-Cell Leukemia (Leukemia, T Cell) 04/2003 - 08/2002

Drug/Important Bio-Agent (IBA)

10	Botulinum Toxins (Botulinum Toxin)IBA 01/2022 - 05/2003
9	Biomarkers (Surrogate Marker)IBA 10/2021 - 12/2013
8	Type A Botulinum Toxins (Botox)FDA Link 01/2022 - 08/2010
8	Dopamine (Intropin)FDA LinkGeneric 06/2017 - 11/2005
7	CytokinesIBA 01/2019 - 08/2002
7	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2003
6	mecobalamin (methylcobalamin)IBA 01/2022 - 01/2014
6	AntibodiesIBA 12/2013 - 04/2007
6	InterleukinsIBA 11/2013 - 07/2002
5	Pharmaceutical PreparationsIBA 01/2020 - 04/2006
4	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2022 - 09/2009
4	incobotulinumtoxinA FDA Link 01/2022 - 01/2020
4	UbiquitinIBA 02/2019 - 08/2008
4	Intravenous Immunoglobulins (IVIG)FDA Link 12/2017 - 03/2008
4	Levodopa (L Dopa)FDA LinkGeneric 08/2008 - 03/2006
3	rimabotulinumtoxinB FDA Link 01/2022 - 02/2013
3	ChemokinesIBA 01/2019 - 11/2014
3	Zolpidem (Ambien)FDA LinkGeneric 05/2016 - 01/2012
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2015 - 03/2003
3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2014 - 08/2010
3	Tacrolimus (Prograf)FDA LinkGeneric 12/2013 - 09/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2013 - 09/2004
3	Interleukin-10 (Interleukin 10)IBA 02/2005 - 08/2002
2	CholesterolIBA 01/2022 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2022 - 09/2017
2	Immunoglobulin G (IgG)IBA 12/2020 - 12/2017
2	Superoxide Dismutase-1IBA 02/2019 - 02/2011
2	AutoantibodiesIBA 04/2018 - 10/2012
2	Edrophonium (Tensilon)FDA LinkGeneric 09/2017 - 01/2016
2	Phosphotransferases (Kinase)IBA 01/2017 - 05/2009
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017 - 07/2011
2	Amantadine (Aman)FDA LinkGeneric 05/2016 - 01/2015
2	Glutamic Acid (Glutamate)FDA Link 05/2016 - 01/2014
2	Ion Channels (Ion Channel)IBA 11/2015 - 06/2011
2	Glucose (Dextrose)FDA LinkGeneric 11/2015 - 01/2013
2	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 09/2015 - 01/2014
2	Neuroprotective AgentsIBA 09/2015 - 07/2015
2	PotassiumIBA 06/2015 - 12/2010
2	SodiumIBA 01/2014 - 01/2013
2	Glutamate Receptors (Glutamate Receptor)IBA 10/2012 - 05/2012
2	imidazopyridineIBA 01/2012 - 01/2012
2	Potassium Channels (Potassium Channel)IBA 11/2011 - 11/2011
2	GangliosidesIBA 01/2010 - 03/2003
2	Interleukin-1beta (Interleukin 1 beta)IBA 07/2005 - 07/2002
2	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2005 - 09/2004
2	Interleukin-6 (Interleukin 6)IBA 09/2004 - 08/2002

Therapy/Procedure

16	Therapeutics 01/2022 - 04/2006
10	Deep Brain Stimulation 09/2020 - 10/2008
5	Injections 01/2021 - 08/2010
5	Activities of Daily Living (ADL) 12/2013 - 04/2006
4	Tracheostomy 01/2022 - 06/2015
2	Drug Therapy (Chemotherapy) 05/2021 - 10/2006